Pelthos Therapeutics (PTHS) Q2 2026 Earnings

14MayConfirmed
Q1 1
Q3 2025
Q4 2025
Q2 2026
-5.3
-3.72
-2.15
-0.58

Details

Expected EPS
-3.45
Actual EPS
-3.09
Surprise EPS
0.36
Surprise Percent
+10.43%

Description

Pelthos Therapeutics (PTHS) has reported earnings of -3.09 per share for Q2 2026.

0 Comments

Share your thoughts